AstraZeneca PLC — Major Shareholding Notification 2021

Jan 13, 2021

Issuer AstraZeneca PLC

Holder

The Capital Group Companies, Inc.

Instrument

Instrument	Common Stock GB0009895292
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Other
Date	04/01/2021
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	88,267,910
Directly held voting rights	0
Indirectly held voting rights	88,267,910
Percentage
Directly held shares	6.72431 %
Directly held voting rights	0 %
Indirectly held voting rights	6.72431 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	6.72431 %	88,267,910
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	6.72431 %	88,267,910

Chain of controlling companies

Percentage of voting rights 6.72431

Voting rights % Voting rights Company 83,790,118 6.38318 Capital Research and Management Company 2,251,845 0.17155 Capital International, Inc.

1,875,177 0.14285		Capital Bank and Trust Company
189,816	0.01446	Capital International Sarl
160,954	0.01226	Capital International Limited
Group total holdings
Voting rights		88,267,910

Notes (other relevant informations according to law)

Changes due to: Following the exit of the United Kingdom from the European Union and the end of the transition period, we understand that disclosures in the UK will no longer be recognized by EU/EEA states effective 1 January 2021. We are not aware of AstraZeneca PLC's new Home Member State for TR-1 forms for major shareholders. Following guidance from ESMA, we will disclose where AstraZeneca PLC is admitted to trading. Therefore, we are filing an initial disclosure for AstraZeneca PLC in Sweden.

Published

13/01/2021 09:08

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25